selected publications

• academic article

  • Crosslinked chitosan microparticles as a safe and efficient DNA carrier for intranasal vaccination against cutaneous leishmaniasis.  Vaccine X.  15:100403-100403. 2023
  • In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis.  Pharmaceutics.  15:51-51. 2022
  • Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis.  Microbes and Infection.  24:104884-104884. 2021
  • Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles.  International Journal for Parasitology Drugs and Drug Resistance.  11:148-155. 2019

• conference paper

  • An effective and reproducible way of tailoring chitosan microspheres properties for intranasal delivery of drugs and vaccines.  . 2012